Updating a meta analysis of intervention research with challenging behaviour

Posted by / 06-Mar-2020 11:22

Updating a meta analysis of intervention research with challenging behaviour

Google(); req('single_work'); $('.js-splash-single-step-signup-download-button').one('click', function(e){ req_and_ready('single_work', function() ); new c. Background: This meta-analysis of interventions with challenging behaviour in children with disabilities updates a comprehensive meta-analysis that previously addressed reported standards of practice and effectiveness of different strategies.Pooled Analysis of Change in Weight at 24 Months in Behavior-Based Weight Loss Interventions Compared With Controls (Key Question 2)e Figure 3. doi:10.1016/j.amepre.20Pub Med Google Scholar Crossref Steeves JA, Liu B, Willis G, Lee R, Smith AW. doi:10.1016/20Pub Med Google Scholar Crossref Kraschnewski JL, Sciamanna CN, Stuckey HL, et al. doi:10.1097/MLR.0b013e3182726c33Pub Med Google Scholar Crossref Ma J, Xiao L, Yank V. doi:10.1002/oby.20285Pub Med Google Scholar Crossref Simkin-Silverman LR, Gleason KA, King WC, et al. doi:10.1016/j.ypmed.20Pub Med Google Scholar Crossref Stafford RS, Farhat JH, Misra B, Schoenfeld DA. doi:10.1001/archfami.9.7.631Pub Med Google Scholar Crossref Moyer VA; U. Pooled Analysis of Change in Weight at 12-18 Months in Behavior-Based Weight Maintenance Interventions Compared With Controls (Key Question 2)e Figure 4. primary care physicians’ diet-, physical activity-, and weight-related care of adult patients. Physicians’ personal beliefs about weight-related care and their associations with care delivery: the U. National Survey of Energy Balance Related Care Among Primary Care Physicians. A silent response to the obesity epidemic: decline in US physician weight counseling. Variations between obese Latinos and whites in weight-related counseling during preventive clinical visits in the United States. Predictors of weight control advice in primary care practices: patient health and psychosocial characteristics. National patterns of physician activities related to obesity management. Population Characteristics for All Randomized Clinical Trials, Sorted by Intervention Type and Author (k=124)e Table 3. Preventive Services Task Force Evidence Syntheses, Formerly Systematic Evidence Reviews. Weight Loss Intervention Components in All Behavior-Based Weight Loss Randomized Clinical Trialse Table 4. Pub Med Google Scholar Le Blanc E, O’Connor E, Whitlock EP, Patnode C, Kapka T. Rockville, MD: Agency for Healthcare Research and Quality; 2011. Guidance for Industry: Developing Products for Weight Management: Draft Guidance. Centers for Disease Control and Prevention website. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Body-mass index and mortality among 1.46 million white adults. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Estimating deaths attributable to obesity in the United States. Body-mass index and mortality in a prospective cohort of U.

Contact us if you experience any difficulty logging in.

No relevant outcomes: Study did not have relevant outcomes or had incomplete outcomes. doi:10.1002/oby.21226Pub Med Google Scholar Crossref Svetkey LP, Stevens VJ, Brantley PJ, et al; Weight Loss Maintenance Collaborative Research Group. doi:10.1001/jama.2Pub Med Google Scholar Crossref Swinburn BA, Carey D, Hills AP, et al. doi:10.1111/j.1463-1326.2004.00467.x Pub Med Google Scholar Crossref Torgerson JS, Hauptman J, Boldrin MN, Sjöström L. doi:10.2337/diacare.27.1.155Pub Med Google Scholar Crossref Tsai AG, Wadden TA, Rogers MA, Day SC, Moore RH, Islam BJ. doi:10.1038/oby.2009.457Pub Med Google Scholar Crossref Tuomilehto J, Lindström J, Eriksson JG, et al; Finnish Diabetes Prevention Study Group. doi:10.1056/NEJM200105033441801Pub Med Google Scholar Crossref Van Gaal LF, Broom JI, Enzi G, Toplak H; Orlistat Dose-Ranging Study Group. doi:10.1007/s002280050433Pub Med Google Scholar Crossrefvan Wier MF, Dekkers JC, Hendriksen IJ, et al. doi:10.1097/JOM.0b013e31821f2bbb Pub Med Google Scholar Crossref Voils CI, Olsen MK, Gierisch JM, et al. doi:10.7326/M16-2160Pub Med Google Scholar Crossrefvon Gruenigen V, Frasure H, Kavanagh MB, et al. doi:10.1016/j.ygyno.20Pub Med Google Scholar Crossref Wadden TA, Volger S, Sarwer DB, et al. doi:10.1056/NEJMoa1109220Pub Med Google Scholar Crossref Wadden TA, Foreyt JP, Foster GD, et al. doi:10.1038/oby.2010.147Pub Med Google Scholar Crossref Wadden TA, Hollander P, Klein S, et al; NN8022-1923 Investigators. doi:10.1038/ijo.2013.120Pub Med Google Scholar Crossref Wing RR, Venditti E, Jakicic JM, Polley BA, Lang W. doi:10.2337/diacare.21.3.350Pub Med Google Scholar Crossref Wylie-Rosett J, Swencionis C, Ginsberg M, et al. doi:10.1016/S0002-8223(01)00284-XPub Med Google Scholar Crossref Yeh MC, Heo M, Suchday S, et al. doi:10.1111/dme.12848Pub Med Google Scholar Crossref Young MD, Callister R, Collins CE, Plotnikoff RC, Aguiar EJ, Morgan PJ. doi:10.1002/oby.21696Pub Med Google Scholar Crossref Beeken RJ, Leurent B, Vickerstaff V, et al. doi:10.1038/ijo.2016.206Pub Med Google Scholar Crossref Fischer HH, Fischer IP, Pereira RI, et al. doi:10.2337/dc15-2137Pub Med Google Scholar Crossref Jenkins DJA, Boucher BA, Ashbury FD, et al. doi:10.1016/20Pub Med Google Scholar Crossref O’Brien MJ, Perez A, Scanlan AB, et al. doi:10.1016/j.amepre.20Pub Med Google Scholar Crossref Thomas JG, Raynor HA, Bond DS, et al. doi:10.1002/oby.21846Pub Med Google Scholar Crossref Ahern AL, Wheeler GM, Aveyard P, et al. doi:10.1016/S0140-6736(17)30647-5Pub Med Google Scholar Crossref Logue E, Sutton K, Jarjoura D, Smucker W, Baughman K, Capers C. doi:10.1038/oby.2005.106Pub Med Google Scholar Crossref Mensink M, Corpeleijn E, Feskens EJ, et al. doi:10.1016/S0168-8227(03)00067-6Pub Med Google Scholar Crossref Whelton PK, Appel LJ, Espeland MA, et al; TONE Collaborative Research Group. doi:10.1001/jama.2Pub Med Google Scholar Crossref Nilsen V, Bakke PS, Gallefoss F. doi:10.1186/1471-2458-11-893Pub Med Google Scholar Crossref Kumanyika SK, Fassbender JE, Sarwer DB, et al. study of weight management in primary care practices. Effectiveness of a motivational intervention on overweight/obese patients in the primary healthcare: a cluster randomized trial. Effect of an internet-based program on weight loss for low-income postpartum women: a randomized clinical trial. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, Phase I. Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study—secondary analysis of the randomized trial. The effect of intentional weight loss on all-cause mortality in older adults: results of a randomized controlled weight-loss trial. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the Diabetes Prevention Program. Patient-reported outcomes in the practice-based opportunities for weight reduction (POWER) trial. Impact of lifestyle intervention and metformin on health-related quality of life: the Diabetes Prevention Program randomized trial. Changes in health state utilities with changes in body mass in the Diabetes Prevention Program. Quality of life outcomes from the Exercise and Nutrition Enhance Recovery and Good Health for You (ENERGY) randomized weight loss trial among breast cancer survivors. Self-efficacy, quality of life, and weight loss in overweight/obese endometrial cancer survivors (SUCCEED): a randomized controlled trial. The impact of a primary care-based weight loss intervention on the quality of life. Weight change, psychological well-being, and vitality in adults participating in a cognitive-behavioral weight loss program. Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years. Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes. Intentional weight loss and death in overweight and obese U.

Reporting of outcomes: Outcomes not presented in a way that could be abstracted for the review. doi:10.2337/dc10-2115Pub Med Google Scholar Crossref Kim SH, Abbasi F, Lamendola C, et al. doi:10.2337/dc13-0354Pub Med Google Scholar Crossref Knowler WC, Barrett-Connor E, Fowler SE, et al; Diabetes Prevention Program Research Group. doi:10.1056/NEJMoa012512Pub Med Google Scholar Crossref Krempf M, Louvet JP, Allanic H, Miloradovich T, Joubert JM, Attali JR. doi:10.1038/0802281Pub Med Google Scholar Crossref Kuller LH, Pettee Gabriel KK, Kinzel LS, et al. doi:10.1038/oby.2011.80Pub Med Google Scholar Crossref Kulzer B, Hermanns N, Gorges D, Schwarz P, Haak T. doi:10.2337/dc08-2141Pub Med Google Scholar Crossref Lindgärde F. doi:10.1046/j.1365-2796.2000.00720.x Pub Med Google Scholar Crossref Little P, Stuart B, Hobbs FR, et al. doi:10.1016/S2213-8587(16)30099-7Pub Med Google Scholar Crossref Luley C, Blaik A, Götz A, et al. doi:10.1080/07315724.2013.875437Pub Med Google Scholar Crossref Ma J, Yank V, Xiao L, et al. doi:10.1001/2013.jamainternmed.987Pub Med Google Scholar Crossref Marrero DG, Palmer KN, Phillips EO, Miller-Kovach K, Foster GD, Saha CK. doi:10.2105/AJPH.2015.303035Pub Med Google Scholar Crossref Martin CK, Redman LM, Zhang J, et al. doi:10.1210/jc.2010-1848Pub Med Google Scholar Crossref Martin PD, Dutton GR, Rhode PC, Horswell RL, Ryan DH, Brantley PJ. doi:10.1038/oby.2008.399Pub Med Google Scholar Crossref Mitsui T, Shimaoka K, Tsuzuku S, Kajioka T, Sakakibara H. doi:10.1620/tjem.215.355Pub Med Google Scholar Crossref Moore H, Summerbell CD, Greenwood DC, et al. doi:10.1136/bmj.327.7423.1085Pub Med Google Scholar Crossref Morgan PJ, Lubans DR, Collins CE, Warren JM, Callister R. doi:10.1038/oby.2010.119Pub Med Google Scholar Crossref Muls E, Kolanowski J, Scheen A, Van Gaal L; Obel Hyx Study Group. doi:10.1038/0801814Pub Med Google Scholar Crossref Nakade M, Aiba N, Suda N, et al; SCOP Group. Pub Med Google Scholar Nanchahal K, Power T, Holdsworth E, et al. doi:10.1136/bmjopen-2011-000793Pub Med Google Scholar Crossref Nicklas JM, Zera CA, England LJ, et al. doi:10.1097/AOG.0000000000000420Pub Med Google Scholar Crossref Ockene IS, Tellez TL, Rosal MC, et al. doi:10.2105/AJPH.2011.300357Pub Med Google Scholar Crossref Parikh P, Simon EP, Fei K, Looker H, Goytia C, Horowitz CR. doi:10.2105/AJPH.2009.170910Pub Med Google Scholar Crossref Patrick K, Calfas KJ, Norman GJ, et al. doi:10.1007/s12160-011-9296-7Pub Med Google Scholar Crossref Pekkarinen T, Kaukua J, Mustajoki P. doi:10.1155/2015/651460Pub Med Google Scholar Crossref Penn L, White M, Oldroyd J, Walker M, Alberti KG, Mathers JC. doi:10.1186/1471-2458-9-342Pub Med Google Scholar Crossref Perri MG, Mc Allister DA, Gange JJ, Jordan RC, Mc Adoo G, Nezu AM. doi:10.1037/0022-006X.56.4.529Pub Med Google Scholar Crossref Pi-Sunyer X, Astrup A, Fujioka K, et al; SCALE Obesity and Prediabetes NN8022-1839 Study Group. doi:10.1056/NEJMoa1411892Pub Med Google Scholar Crossref Puhkala J, Kukkonen-Harjula K, Mansikkamäki K, et al. doi:10.5271/sjweh.3463Pub Med Google Scholar Crossref Richelsen B, Tonstad S, Rössner S, et al. doi:10.2337/dc06-0210Pub Med Google Scholar Crossref Rock CL, Flatt SW, Byers TE, et al. doi:10.1200/JCO.20Pub Med Google Scholar Crossref Rock CL, Pakiz B, Flatt SW, Quintana EL. doi:10.1038/oby.2007.614Pub Med Google Scholar Crossref Rosas LG, Thiyagarajan S, Goldstein BA, et al. doi:10.1016/20Pub Med Google Scholar Crossref Ross R, Lam M, Blair SN, et al. doi:10.1001/archinternmed.2011.1972Pub Med Google Scholar Crossref Rössner S, Sjöström L, Noack R, Meinders AE, Noseda G; European Orlistat Obesity Study Group. doi:10.1038/oby.2000.8Pub Med Google Scholar Crossref Shapiro JR, Koro T, Doran N, et al. doi:10.1016/j.ypmed.20Pub Med Google Scholar Crossref Sherwood NE, Crain AL, Martinson BC, et al. doi:10.1016/j.ypmed.20Pub Med Google Scholar Crossref Silva MN, Vieira PN, Coutinho SR, et al. doi:10.1007/s10865-009-9239-y Pub Med Google Scholar Crossref Simpson SA, Mc Namara R, Shaw C, et al. doi:10.3310/hta19500Pub Med Google Scholar Crossref Sjöström L, Rissanen A, Andersen T, et al; European Multicentre Orlistat Study Group. doi:10.1016/S0140-6736(97)11509-4Pub Med Google Scholar Crossref Smith SR, Stenlof KS, Greenway FL, et al. doi:10.1038/oby.2011.143Pub Med Google Scholar Crossref Smith SR, Weissman NJ, Anderson CM, et al; Behavioral Modification and Lorcaserin for Overweight and Obesity Management (BLOOM) Study Group. doi:10.1056/NEJMoa0909809Pub Med Google Scholar Crossref Smith TJ, Crombie A, Sanders LF, et al. doi:10.1016/20Pub Med Google Scholar Crossref Stevens VJ, Corrigan SA, Obarzanek E, et al; TOHP Collaborative Research Group. doi:10.1001/archinte.1993.00410070039006Pub Med Google Scholar Crossref Stevens VJ, Obarzanek E, Cook NR, et al; Trials for the Hypertension Prevention Research Group. doi:10.7326/0003-4819-134-1-200101020-00007Pub Med Google Scholar Crossref Svetkey LP, Batch BC, Lin PH, et al. Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial. Effect of orlistat on cardiovascular disease risk in obese adults. XENical in the prevention of Diabetes in Obese Subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. A primary care intervention for weight loss: results of a randomized controlled pilot study. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. Efficacy and tolerability of orlistat in the treatment of obesity: a 6-month dose-ranging study. Effectiveness of phone and e-mail lifestyle counseling for long term weight control among overweight employees. Maintenance of weight loss after initiation of nutrition training: a randomized trial. Survivors of uterine cancer empowered by exercise and healthy diet (SUCCEED): a randomized controlled trial. A two-year randomized trial of obesity treatment in primary care practice. Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study [published corrections appear in Int J Obes (Lond). Lifestyle intervention in overweight individuals with a family history of diabetes. Computerized weight loss intervention optimizes staff time: the clinical and cost results of a controlled clinical trial conducted in a managed care setting. Translation of the Diabetes Prevention Program for diabetes risk reduction in Chinese immigrants in New York City. Efficacy of a gender-tailored intervention to prevent weight regain in men over 3 years: a weight loss maintenance RCT. A brief intervention for weight control based on habit-formation theory delivered through primary care: results from a randomised controlled trial. Text message support for weight loss in patients with prediabetes: a randomized clinical trial. Effect of current dietary recommendations on weight loss and cardiovascular risk factors. PREVENT-DM comparative effectiveness trial of lifestyle intervention and metformin. Weight loss in Weight Watchers Online with and without an activity tracking device compared to control: a randomized trial. Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trial. Transtheoretical model–chronic disease care for obesity in primary care: a randomized trial. Study on lifestyle-intervention and impaired glucose tolerance Maastricht (SLIM): design and screening results. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). Effects of lifestyle intervention in persons at risk for type 2 diabetes mellitus—results from a randomised, controlled trial.

doi:10.1056/NEJM199910073411501Pub Med Google Scholar Crossref Flegal KM, Kit BK, Orpana H, Graubard BI. doi:10.1001/jama.2012.113905Pub Med Google Scholar Crossref Yu E, Ley SH, Manson JE, et al. doi:10.7326/M16-1390Pub Med Google Scholar Crossref Flegal KM, Ioannidis JPA. doi:10.1016/j.jclinepi.20Pub Med Google Scholar Crossref Padwal RS, Pajewski NM, Allison DB, Sharma AM.

Access to society journal content varies across our titles.

updating a meta analysis of intervention research with challenging behaviour-16updating a meta analysis of intervention research with challenging behaviour-35updating a meta analysis of intervention research with challenging behaviour-65

One thought on “updating a meta analysis of intervention research with challenging behaviour”